Eli Lilly is starting a late-stage study of its coronavirus antibody drug in nursing homes. MegTirrell has the details.
An Eli Lilly & Co. logo is seen on the cap of a pill bottle in this arranged photograph at a pharmacy in Princeton, Illinois.said on Monday it is beginning a late-stage trial to study whether one of its experimental Covid-19 antibody treatments can prevent the virus' spread in residents and staff in U.S. nursing homes.
"Covid-19 has had a devastating impact on nursing home residents," Lilly's chief scientific officer Daniel Skovronsky said in a statement. "We're working as fast as we can to create medicines that might stop the spread of the virus to these vulnerable individuals." It is launching the phase 3 trial in partnership with several long-term care facility networks across the country as well as the U.S. National Institute of Allergy and Infectious Diseases .
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly launches late-stage antibody treatment trial to be tested in US nursing homesEli Lilly is launching a late-stage study of its monoclonal antibody technology, and has employed a mobile treatment van to deliver this therapy to nursing homes.
Read more »
Eli Lilly launches late-stage antibody treatment trial to be tested in US nursing homesEli Lilly is launching a late-stage study of its monoclonal antibody technology, and has employed a mobile treatment van to deliver this therapy to nursing homes.
Read more »
Baseball Draws Strong TV Ratings in Opening Week Amid Uncertainty Over SeasonThe start of the Major League Baseball season, four-months late due to the coronavirus pandemic, has drawn strong ratings—a boon for content-starved sports networks.
Read more »
‘I have nightmares all the time’: Nurses speak out about the mental toll of COVID-19'When all this is over, whenever that is, I'll have some serious healing to do,' Krista Perry, an ICU nurse in Arizona, told TODAY.
Read more »
As vaccines move into phase 3 trials, diversity must be at top of agendaEnsuring Black and ethnic minority participation in coronavirus vaccine trials is key if we want a truly effective coronavirus vaccine, according to experts.
Read more »
Scientists study coronavirus outbreaks among minks in EuropeCoronavirus outbreaks at mink farms in Spain and the Netherlands have scientists digging into how the animals got infected and weather they can spread it to people.
Read more »